Ilan Goldenberg

What is the role of ICDs for primary prevention of SCD with contemporary HFrEF therapy? Looking forward to the new PCORI funded 3000+ patient outcomes trial. ⁦@ilangoldenberg⁩ ⁦⁦@WojciechZareba⁩ ⁦@JustinEzekowitz⁩

URMC Heart Researchers Launch $27M ICD Study urmc.rochester.edu/news/story/urm…

Our late breaking science presentation at the Heart Rhythm Society conference on combined S-ICD and VT ablation for the prevention of sudden cardiac death received media attention: healio.com/news/cardiolog… @UR_Med @oreganruth

The results of our International novel VT-Ablation (using ultra high-density electroanatomic Rhythmia mapping) combined with S-ICD (VTabl-SICD) trial will be featured on Saturday at HRS as a late breaking Science presentation

At the Heart Rhythm Society conference in San Francisco this week our @UofR @URMC_DeptMed medical students, residents, cardiology fellows and faculty had a record number of 12 presentations! @MilicaBjelic5

Below is also a link to an article published by Medscape on our @HRSonline Late Breaking Presentation (published also simultaneously at @hrs_journal) @UofR @URMC_DeptMed medpagetoday.com/meetingcoverag…

Here's a link to a clip from my presentation at the Late Breaking Innovation Session of the @HRSonline Heart Rhythm Society of our groundbreaking study conducted at the @UofR @URMC_DeptMed on sex hormones during the menstrual cycle and long QT urldefense.proofpoint.com/v2/url?u=https…

Here's a link to a summary of our recent AHA late breaker on the effect of SGLT2i on atrial arrhythmia: radcliffecardiology.com/video-index/ah…

"Use of Oral Contraceptives in Women with Congenital Long QT Syndrome" by Ilan Goldenberg et al had been accepted by Heart Rhythm. The paper will be published simultaneously with LBCT abstract presentation during HRS meeting next week.

Congratulations to Dr. Hima Vidula for leading and developing the unique TeleVAD Program at the University of Rochesterhttps://www.urmc.rochester.edu/news/story/heartbeat-of-community-stronger-thanks-to-remote-televad-program-in-hornell

The academic year for the Cardiology Grands Rounds at the University of Rochester ended today. Here is the link to the recordings of our high-level presentations, involving external and internal speakers addressing innovative cardiology topics: urmc.rochester.edu/cardiology/edu… @UR_Med

Our NIH Award for a randomized clinical trial at the University of Rochester on atrial fibrillation management following ablation based on subclinical AF (using an insertable cardiac monitor) was activated today. @UR_Med

Congratulations also to Dr. David Huang who received his first RO1 to study intraoperative VT ablation in LVAD patients. Dr. Huang and our experienced advanced heart failure/cardiac surgery teams will lead this important multicenter clinical trial in the US @UR_Med @URMed_AHF

The NIH Awarded RO1 of @himavidula will evaluate a very important topic: identification of a blood pressure threshold for the prevention of stroke in LVAD patients in the setting of a prospective multicenter clinical study headed by Dr. Vidula @URMed_AHF @UR_Med @UofR

Nice - very important topic and study.

New publication based on our landmark MADIT trial #Cardiology #electrophysiology #defibrillator #URochesterResearch #URMC Survival After Implantable Cardioverter-Defibrillator Shocks pubmed.ncbi.nlm.nih.gov/34016257/

Our Cardiovascular Research Center at the University of Rochester received approval this week for 5! new NIH grants (in the fields of novel treatment of atrial fibrillation, management of LVAD patients, and device therapy for heart failure)

We have initiated this week the CONFIRM-AF study. Randomized multisite clinical trial (30 sites) coordinated by our center at the University of Rochester for early detection of atrial fibrillation using an insertable cardiac monitor in patients with heart failure.